• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Madrigal Pharmaceuticals

Lifeline
Favicon Fierce Biotech

Midsize biotechs form coalition to fight against MFN policy

A group of 10 domestic, medium-sized biotechs launched the Midsized Biotech Alliance of America to advocate for free-market solutions to drug policy.
Will Maddox Feb 25, 2026 1:05pm
Rezdiffra

Madrigal embraces Novo competition as MASH drug gains steam

Feb 19, 2026 2:16pm
Asia

Lilly-Innovent, AstraZeneca, Madrigal—Fierce Pharma Asia

Feb 13, 2026 8:25am
Rezdiffra

Madrigal's MASH drug Rezdiffra posts 35% sales increase in Q3

Nov 5, 2025 12:02pm
ChatGPT said  Low-poly magenta liver model centered on a pale blue background patterned with sketchy dollar signs suggestin

Big Pharma bets big on MASH with a new combo playbook

Oct 17, 2025 9:30am
liver

With key FDA nod in MASH, Novo's Wegovy scores 3rd indication

Aug 18, 2025 10:08am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings